EAM
EVH icon

Eventide Asset Management’s Evolent Health EVH Stock Holding History

Eventide Asset Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.81M Buy
+2,547,558
New +$8.08M 0.1% 157
2025
Q4 		– Sell
-6,292,511
Closed -$53.2M – 274
2025
Q3 		$53.2M Buy
6,292,511
+2,205,659
+54% +$21.4M 0.88% 36
2025
Q2 		$46M Sell
4,086,852
-1,990,339
-33% -$18.3M 0.81% 39
2025
Q1 		$57.6M Buy
6,077,191
+1,524,885
+33% +$15.4M 1.15% 24
2024
Q4 		$51.2M Buy
4,552,306
+748,202
+20% +$13.1M 0.93% 35
2024
Q3 		$108M Buy
3,804,104
+64,985
+2% +$1.67M 1.85% 11
2024
Q2 		$71.5M Buy
3,739,119
+1,096,551
+41% +$28M 1.22% 25
2024
Q1 		$86.6M Buy
2,642,568
+3,622
+0.1% +$116K 1.36% 19
2023
Q4 		$87.2M Buy
2,638,946
+6
+0% +$170 1.42% 22
2023
Q3 		$71.9M Buy
2,638,940
+796
+0% +$22.1K 1.29% 26
2023
Q2 		$79.9M Buy
2,638,144
+735,389
+39% +$23.8M 1.35% 22
2023
Q1 		$61.7M Hold
1,902,755
– – 1.13% 27
2022
Q4 		$53.4M Buy
1,902,755
+1,686,055
+778% +$48.3M 1.05% 33
2022
Q3 		$7.79M Hold
216,700
– – 0.15% 111
2022
Q2 		$6.66M Buy
+216,700
New +$6.31M 0.14% 110

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Eventide Asset Management's EVH Position: Q1 2026 in Review

Eventide Asset Management opened a new position in Evolent Health (EVH) in Q1 2026: 2,547,558 shares worth $5.81M. The stake represents 0.1% of the portfolio and ranks #157 among its holdings. This is a return to the name: Eventide Asset Management previously reported a position in EVH as recently as Q3 2025.

Eventide Asset Management first reported a position in EVH in Q2 2022 and has held it in 15 quarters since. The position peaked at $108M in Q3 2024. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Eventide Asset Management held 2,547,558 shares of Evolent Health worth $5.81M as of Q1 2026.
  • Evolent Health was a new Eventide Asset Management position in Q1 2026.
  • Evolent Health made up 0.1% of Eventide Asset Management's portfolio in Q1 2026, its #157 holding.
  • Eventide Asset Management first reported a position in Evolent Health in Q2 2022 and has held it in 15 quarters since.
  • Eventide Asset Management's Evolent Health position peaked at $108M in Q3 2024.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Eventide Asset Management's 13F filing for Q1 2026, filed 15 May 2026.